Actively Recruiting

Age: 18Years +
All Genders
NCT04528511

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

Led by Shanghai 10th People's Hospital · Updated on 2026-03-19

774

Participants Needed

5

Research Sites

404 weeks

Total Duration

On this page

Sponsors

S

Shanghai 10th People's Hospital

Lead Sponsor

S

Shanghai Tong Ren Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.

CONDITIONS

Official Title

BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (>18 years old)
  • Patients with acute myocardial infarction (including STEMI and NSTEMI) who developed new-onset atrial fibrillation during the hospital stay
  • Patients who have received continuous electronic monitoring for at least 5 days during hospitalization
  • Patients who provide informed consent
Not Eligible

You will not qualify if you...

  • Patients with a history of pre-existing atrial fibrillation
  • Patients with rheumatic valvular disease
  • Patients with sick sinus syndrome
  • Patients undergoing emergency coronary artery bypass surgery
  • Patients with malignant tumors expected to live less than 1 year
  • Patients who refuse continuous electronic monitoring or whose heart rhythm data cannot be obtained
  • Patients who refuse or cannot undergo percutaneous coronary intervention (PCI)
  • Patients who died during the hospital stay

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Kaifeng Central Hospital

Kaifeng, Henan, China

Actively Recruiting

2

Luoyang Central Hospital

Luoyang, Henan, China

Actively Recruiting

3

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Actively Recruiting

4

Department of Cardiology, Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, China, 200072

Actively Recruiting

5

Shanghai Seventh People's Hospital

Shanghai, Shanghai Municipality, China

Actively Recruiting

Loading map...

Research Team

J

Jiachen Luo, M.D., Ph.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here